-
Je něco špatně v tomto záznamu ?
α-Synuclein aggregation at low concentrations
K. Afitska, A. Fucikova, VV. Shvadchak, DA. Yushchenko,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- alfa-synuklein chemie metabolismus MeSH
- amyloid chemie metabolismus MeSH
- cirkulární dichroismus MeSH
- fluorescenční spektrometrie MeSH
- lidé MeSH
- proteinové agregáty * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Aggregation of the neuronal protein α-synuclein into amyloid fibrils is a hallmark of Parkinson's disease. The propensity of α-synuclein to aggregate increases with the protein concentration. For the development of efficient inhibitors of α-synuclein aggregation, it is important to know the critical concentration of aggregation (the concentration of monomeric protein, below which the protein does not aggregate). METHODS: We performed in vitro aggregation studies of α-synuclein at low concentrations (0.11-20 μM). Aggregation kinetics was measured by ThT fluorescence. Obtained aggregates were characterized using CD-spectroscopy, fluorescent spectroscopy, dynamic light scattering and AFM imaging. RESULTS: Monomeric α-synuclein at concentrations 0.45 μM and above was able to bind to fibril ends resulting in fibril growth. At the protein concentrations below 0.4 μM, monomers did not fibrillize, and fibrils disaggregated. In the absence of seeds, fibrils were formed only at monomer concentrations higher than 10 μM. At low micromolar concentrations, we observed formation of prefibrillar amyloid aggregates, which are able to induce fibril formation in α-synuclein solutions of high concentrations. CONCLUSIONS: The critical concentration of α-synuclein fibril growth is ~0.4 μM. Prefibrillar amyloid aggregates appear at concentrations between 0.45 and 3 μM and are an intermediate state between monomers and fibrils. Although morphologically different from fibrils, prefibrillar aggregates have similar properties to those of fibrils. GENERAL SIGNIFICANCE: We determined the critical concentration of α-synuclein fibril growth. We showed that fibrils can grow at much lower monomer concentrations than that required for de novo fibril formation. We characterized a prefibrillar intermediate species formed upon aggregation of α-synuclein at low micromolar concentration.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044828
- 003
- CZ-PrNML
- 005
- 20200113084624.0
- 007
- ta
- 008
- 200109s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbapap.2019.05.003 $2 doi
- 035 __
- $a (PubMed)31096048
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Afitska, Kseniia $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo namesti 2, Prague 16610, Czech Republic; Department of Biochemistry, Faculty of Science, Charles University, Albertov 6, Prague 12843, Czech Republic.
- 245 10
- $a α-Synuclein aggregation at low concentrations / $c K. Afitska, A. Fucikova, VV. Shvadchak, DA. Yushchenko,
- 520 9_
- $a BACKGROUND: Aggregation of the neuronal protein α-synuclein into amyloid fibrils is a hallmark of Parkinson's disease. The propensity of α-synuclein to aggregate increases with the protein concentration. For the development of efficient inhibitors of α-synuclein aggregation, it is important to know the critical concentration of aggregation (the concentration of monomeric protein, below which the protein does not aggregate). METHODS: We performed in vitro aggregation studies of α-synuclein at low concentrations (0.11-20 μM). Aggregation kinetics was measured by ThT fluorescence. Obtained aggregates were characterized using CD-spectroscopy, fluorescent spectroscopy, dynamic light scattering and AFM imaging. RESULTS: Monomeric α-synuclein at concentrations 0.45 μM and above was able to bind to fibril ends resulting in fibril growth. At the protein concentrations below 0.4 μM, monomers did not fibrillize, and fibrils disaggregated. In the absence of seeds, fibrils were formed only at monomer concentrations higher than 10 μM. At low micromolar concentrations, we observed formation of prefibrillar amyloid aggregates, which are able to induce fibril formation in α-synuclein solutions of high concentrations. CONCLUSIONS: The critical concentration of α-synuclein fibril growth is ~0.4 μM. Prefibrillar amyloid aggregates appear at concentrations between 0.45 and 3 μM and are an intermediate state between monomers and fibrils. Although morphologically different from fibrils, prefibrillar aggregates have similar properties to those of fibrils. GENERAL SIGNIFICANCE: We determined the critical concentration of α-synuclein fibril growth. We showed that fibrils can grow at much lower monomer concentrations than that required for de novo fibril formation. We characterized a prefibrillar intermediate species formed upon aggregation of α-synuclein at low micromolar concentration.
- 650 _2
- $a amyloid $x chemie $x metabolismus $7 D000682
- 650 _2
- $a cirkulární dichroismus $7 D002942
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a proteinové agregáty $7 D066329
- 650 _2
- $a fluorescenční spektrometrie $7 D013050
- 650 _2
- $a alfa-synuklein $x chemie $x metabolismus $7 D051844
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Fucikova, Anna $u Department of Chemical Physics & Optics, Faculty of Mathematics & Physics, Charles University, Ke Karlovu 3, Prague 12116, Czech Republic.
- 700 1_
- $a Shvadchak, Volodymyr V $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo namesti 2, Prague 16610, Czech Republic.
- 700 1_
- $a Yushchenko, Dmytro A $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo namesti 2, Prague 16610, Czech Republic; Miltenyi Biotec GmbH, Friedrich-Ebert-Straße 68, Bergisch Gladbach 51429, Germany. Electronic address: yushchenko@uochb.cas.cz.
- 773 0_
- $w MED00007006 $t Biochimica et biophysica acta. Proteins and proteomics $x 1878-1454 $g Roč. 1867, č. 7-8 (2019), s. 701-709
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31096048 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113084956 $b ABA008
- 999 __
- $a ok $b bmc $g 1483097 $s 1083501
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 1867 $c 7-8 $d 701-709 $e 20190513 $i 1878-1454 $m Biochimica et biophysica acta. Proteins and proteomics $n Biochem Biophys Acta $x MED00007006
- LZP __
- $a Pubmed-20200109